CYPHERPUNK TECHNOLOGIES INC. Interest Expense
CYPHERPUNK TECHNOLOGIES INC. (CYPH) reported Interest Expense of $54.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-18.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-03-18
- CYPHERPUNK TECHNOLOGIES INC. interest expense for the quarter ending 2022-12-31 was $5.00K, a 150.00% increase year-over-year.
- CYPHERPUNK TECHNOLOGIES INC. interest expense for the quarter ending 2022-09-30 was $11.00K, a 22.22% increase year-over-year.
- CYPHERPUNK TECHNOLOGIES INC. interest expense for the quarter ending 2022-06-30 was $17.00K, a 6.25% increase year-over-year.
- CYPHERPUNK TECHNOLOGIES INC. interest expense for the quarter ending 2022-03-31 was $21.00K, a 50.00% increase year-over-year.
- CYPHERPUNK TECHNOLOGIES INC. interest expense for fiscal 2022 was $54.00K, a 31.71% increase from fiscal 2021.
- CYPHERPUNK TECHNOLOGIES INC. interest expense for fiscal 2021 was $41.00K, a 5.13% increase from fiscal 2020.
- CYPHERPUNK TECHNOLOGIES INC. interest expense for fiscal 2020 was $39.00K, a 69.57% increase from fiscal 2019.
- CYPHERPUNK TECHNOLOGIES INC. interest expense for fiscal 2019 was $23.00K, a 21.05% increase from fiscal 2018.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2022-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | $16.00K derived: sum of 2 quarters · filed 2024-03-18 | $33.00K derived: sum of 3 quarters · filed 2024-03-18 | $54.00K 10-K · filed 2024-03-18 |
| 2022-09-30 | $11.00K 10-Q · filed 2023-11-13 | $28.00K derived: sum of 2 quarters · filed 2023-11-13 | $49.00K 10-Q · filed 2023-11-13 | $51.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $17.00K 10-Q · filed 2023-08-14 | $38.00K 10-Q · filed 2023-08-14 | $40.00K derived: sum of 3 quarters · filed 2023-08-14 | $49.00K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $21.00K 10-Q · filed 2023-05-15 | $23.00K derived: sum of 2 quarters · filed 2023-05-15 | $32.00K derived: sum of 3 quarters · filed 2023-05-15 | $48.00K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | $11.00K derived: sum of 2 quarters · filed 2023-03-24 | $27.00K derived: sum of 3 quarters · filed 2023-03-24 | $41.00K 10-K · filed 2023-03-24 |
| 2021-09-30 | $9.00K 10-Q · filed 2022-11-14 | $25.00K derived: sum of 2 quarters · filed 2022-11-14 | $39.00K 10-Q · filed 2022-11-14 | $36.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $16.00K 10-Q · filed 2022-08-12 | $30.00K 10-Q · filed 2022-08-12 | $27.00K derived: sum of 3 quarters · filed 2022-08-12 | $44.00K derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $14.00K 10-Q · filed 2022-05-13 | $11.00K derived: sum of 2 quarters · filed 2022-05-13 | $28.00K derived: sum of 3 quarters · filed 2022-05-13 | $41.00K derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | -$3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $14.00K derived: sum of 2 quarters · filed 2022-03-11 | $27.00K derived: sum of 3 quarters · filed 2022-03-11 | $39.00K 10-K · filed 2022-03-11 |
| 2020-09-30 | $17.00K 10-Q · filed 2021-11-12 | $30.00K derived: sum of 2 quarters · filed 2021-11-12 | $42.00K 10-Q · filed 2021-11-12 | $44.00K derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $13.00K 10-Q · filed 2021-08-13 | $25.00K 10-Q · filed 2021-08-13 | $27.00K derived: sum of 3 quarters · filed 2021-08-13 | $32.00K derived: sum of 4 quarters · filed 2021-08-13 |
| 2020-03-31 | $12.00K 10-Q · filed 2021-05-14 | $14.00K derived: sum of 2 quarters · filed 2021-05-14 | $19.00K derived: sum of 3 quarters · filed 2021-05-14 | $28.00K derived: sum of 4 quarters · filed 2021-05-14 |
| 2019-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $7.00K derived: sum of 2 quarters · filed 2021-03-12 | $16.00K derived: sum of 3 quarters · filed 2021-03-12 | $23.00K 10-K · filed 2021-03-12 |
| 2019-09-30 | $5.00K 10-Q · filed 2020-11-12 | $14.00K derived: sum of 2 quarters · filed 2020-11-12 | $21.00K 10-Q · filed 2020-11-12 | $22.00K derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $9.00K 10-Q · filed 2020-08-13 | $16.00K 10-Q · filed 2020-08-13 | $17.00K derived: sum of 3 quarters · filed 2020-08-13 | $21.00K derived: sum of 4 quarters · filed 2020-08-13 |
| 2019-03-31 | $7.00K 10-Q · filed 2020-05-14 | $8.00K derived: sum of 2 quarters · filed 2020-05-14 | $12.00K derived: sum of 3 quarters · filed 2020-05-14 | $20.00K derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $5.00K derived: sum of 2 quarters · filed 2020-03-16 | $13.00K derived: sum of 3 quarters · filed 2020-03-16 | $19.00K 10-K · filed 2020-03-16 |
| 2018-09-30 | $4.00K 10-Q · filed 2019-11-14 | $12.00K derived: sum of 2 quarters · filed 2019-11-14 | $18.00K 10-Q · filed 2019-11-14 | $534.00K derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | $8.00K 10-Q · filed 2019-08-09 | $14.00K 10-Q · filed 2019-08-09 | $530.00K derived: sum of 3 quarters · filed 2019-08-09 | $551.00K derived: sum of 4 quarters · filed 2019-08-09 |
| 2018-03-31 | $6.00K 10-Q · filed 2019-05-15 | $522.00K derived: sum of 2 quarters · filed 2019-05-15 | $543.00K derived: sum of 3 quarters · filed 2019-05-15 | |
| 2017-12-31 | $516.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $537.00K derived: sum of 2 quarters · filed 2019-04-01 | $528.00K 10-K · filed 2019-04-01 | |
| 2017-09-30 | $21.00K 10-Q · filed 2018-11-09 | $12.00K 10-Q · filed 2018-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |